TECH OUTLOOK 4MAY - 2022Optimizing Clinical Trials: Leveraging Technology to Improve Drug DevelopmentIN MY OPINIONCraig Herron, Managing Director, iSelect Fund (NYSE:BHIL)Shanhu HealthPg 240812COVER STORYClinActisTHE EPITOME OF A RESULT-ORIENTED CRO PARTNERDR. CHRISTOPHE TOURNERIE, CEOTTECH OUTLOOKOP 10SOLUTIONS PROVIDERS IN APAC - 2022CLINICAL TRIALS
< Page 3 | Page 5 >